1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry Within the Industry 6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Rising Prevalence of Chronic & Infectious Diseases in developing economies 6.1.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques 6.1.3 Private Investments and Venture Capital Activities supporting R&D of Novel Products 6.2 Market Restraints 6.2.1 Product Recalls by Major Players Demotivate New Entrants 6.2.2 Stringent Regulatory Policies are Increasing Gestation Period for Product Launches 6.2.3 Reimbursement Cuts Causing Pricing Pressure 6.3 Opportunities 6.4 Key challenges 7. Market Segmentation 7.1 By Product 7.1.1 Glucose Monitoring Kits 7.1.2 Cardio-metabolic Monitoring Kits 7.1.3 Pregnancy and Fertility Testing Kits 7.1.4 Infectious Disease Testing Kits 7.1.5 Cholesterol Test Strips 7.1.6 Hematology Testing Kits 7.1.7 Others 7.2 By End User 7.2.1 Hospitals/Critical Care Settings 7.2.2 Outpatient Healthcare Settings 7.2.3 Ambulatory Care Settings 7.2.4 Research Laboratories 7.2.5 Home Care 7.2.6 Others 7.3 By Geography 7.3.1 North America 7.3.1.1 United States 7.3.1.2 Canada 7.3.1.3 Mexico 7.3.2 Europe 7.3.2.1 France 7.3.2.2 Germany 7.3.2.3 United Kingdom 7.3.2.4 Italy 7.3.2.5 Spain 7.3.2.6 Rest of Europe 7.3.3 Asia-pacific 7.3.3.1 China 7.3.3.2 Japan 7.3.3.3 India 7.3.3.4 Australia & New Zealand 7.3.3.5 South Korea 7.3.3.6 Rest of Asia-Pacific 7.3.4 Middle east & Africa 7.3.4.1 GCC 7.3.4.2 South Africa 7.3.4.3 Rest of the Middle East & Africa 7.3.5 South America 7.3.5.1 Brazil 7.3.5.2 Argentina 7.3.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Abbott 9.2 Siemens AG 9.3 Beckman Coulter Inc. 9.4 Becton, Dickinson and Company 9.5 Instrumentation Laboratory 9.6 Johnson & Johnson 9.7 Nova Biomedical 9.8 Qiagen 9.9 F. Hoffmann-La Roche Ltd 9.10 List Not Exhaustive 10. Future of the Market

Abbott, Beckman Coulter Inc., Becton, Dickinson And Company, Instrumentation Laboratory, Johnson & Johnson, Nova Biomedical, Qiagen, Roche Diagnostics Limited, Siemens Ag